The Crystal Scintillators segmentation by application delineates five primary end‑uses that collectively shape the market’s revenue profile. Medical imaging—principally positron emission tomography (PET) and single‑photon emission computed tomography (SPECT)—accounts for the largest share, roughly 35 %, driven by expanding diagnostic demand and higher detector performance standards. High‑energy physics research, encompassing particle accelerators and collider experiments, follows with an estimated 30 %, reflecting substantial investment in detector upgrades and new facilities. Security screening systems, including cargo and baggage inspection, contribute about 15 %, propelled by stricter regulatory mandates worldwide. The oil & gas exploration sector, utilizing scintillators for gamma‑ray logging and neutron detection, represents 10 %, while industrial nondestructive testing (NDT)—covering weld inspection and material integrity assessments—also holds 10 % of the total. These application‑specific allocations directly translate into distinct demand curves, influencing production volumes, pricing dynamics, and R&D focus across the crystal scintillator value chain.